Survival outcome in early onset metastatic colorectal cancer: a multicenter matched-pair analysis

Conclusion Our study suggests that younger patients benefit at least to the same magnitude or even more from mCRC-treatment than patients aged 50 or above.PMID:37699362 | DOI:10.1159/000533429
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research